EU Regulators Limit Symbioflor 2 to Irritable Bowel Syndrome EU Regulators Limit Symbioflor 2 to Irritable Bowel Syndrome

The European Medicines Agency also directed the company that markets the probiotic to conduct a study on how well it treats variants of IBS.News Alerts

Source: Medscape FamilyMedicine Headlines - June 23, 2017 Category: Primary Care Tags: Gastroenterology News Alert Source Type: news